XT
FOLD

XTX Topco’s Amicus Therapeutics FOLD Stock Holding History

XTX Topco’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-65,467
Closed -$516K – 3459
2025
Q3 		$516K Buy
+65,467
New +$466K 0.03% 1046
2025
Q2 		– Sell
-106,773
Closed -$871K – 2622
2025
Q1 		$871K Buy
106,773
+68,245
+177% +$632K 0.04% 642
2024
Q4 		$363K Buy
38,528
+594
+2% +$6.17K 0.03% 1050
2024
Q3 		$405K Buy
+37,934
New +$413K 0.03% 974
2024
Q2 		– Sell
-11,009
Closed -$130K – 2058
2024
Q1 		$130K Sell
11,009
-18,433
-63% -$236K 0.02% 1298
2023
Q4 		$418K Buy
+29,442
New +$334K 0.09% 370
2023
Q3 		– Sell
-21,416
Closed -$269K – 1698
2023
Q2 		$269K Buy
+21,416
New +$254K 0.05% 794
2021
Q4 		– Sell
-36,094
Closed -$345K – 792
2021
Q3 		$345K Buy
+36,094
New +$369K 0.12% 304
2021
Q2 		– Sell
-15,112
Closed -$149K – 895
2021
Q1 		$149K Buy
+15,112
New +$234K 0.07% 531

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

XTX Topco's FOLD Position: Q4 2025 in Review

XTX Topco sold out of Amicus Therapeutics (FOLD) in Q4 2025, closing a stake of 65,467 shares — an estimated $516K sold.

XTX Topco first reported a position in FOLD in Q1 2021 and held it in 9 quarters. The position peaked at $871K in Q1 2025. 332 funds tracked by Wall St. Rank hold FOLD as of Q4 2025.

  • XTX Topco reported no remaining Amicus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • XTX Topco sold 65,467 Amicus Therapeutics shares in Q4 2025, an estimated $516K.
  • XTX Topco first reported a position in Amicus Therapeutics in Q1 2021 and held it in 9 quarters.
  • XTX Topco's Amicus Therapeutics position peaked at $871K in Q1 2025.
  • 332 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.